Characterisation of clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing

PLoS Medicine

Volumn 9, Issue 2, 2012, Pages

  Walker, A Sarah ^a,b   Eyre, David W ^a   Wyllie, David H ^a   Dingle, Kate E ^a,c   Harding, Rosalind M ^d   O'Connor, Lily ^a   Griffiths, David ^a,e   Vaughan, Ali ^a,e   Finney, John ^a   Wilcox, Mark H ^f,g   Crook, Derrick W ^a,e   Peto, Tim E A ^a,e  

^a NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE TRANSMISSION; HOSPITAL DEPARTMENT; INCUBATION TIME; INFECTION CONTROL; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; CROSS INFECTION; DIARRHEA; ENDEMIC DISEASE; GASTROINTESTINAL TRACT; GENETICS; HOSPITAL SUBDIVISIONS AND COMPONENTS; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PSEUDOMEMBRANOUS COLITIS;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; ENDEMIC DISEASES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GASTROINTESTINAL TRACT; HOSPITAL UNITS; HOSPITALIZATION; HUMANS; INFECTION CONTROL; MULTILOCUS SEQUENCE TYPING;

EID: 84857741366     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001172     Document Type: Article

References (36)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455.
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442-2449.
3. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353: 2433-2441.
4. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, et al. (2008) Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 14 (Suppl 5): 2-20.
5. Muto CA, Blank MK, Marsh JW, Vergis EN, O'Leary MM, et al. (2007) Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 45: 1266-1273.
6. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J, (2007) Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 45 (Suppl 2): S112-S121.
7. Zelner JL, King AA, Moe CL, Eisenberg JN, (2010) How infections propagate after point-source outbreaks: an analysis of secondary norovirus transmission. Epidemiology 21: 711-718.
8. Glynn JR, Palmer SR, (1992) Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am J Epidemiol 136: 1369-1377.
9. Medley GF, Anderson RM, Cox DR, Billard L, (1987) Incubation period of AIDS in patients infected via blood transfusion. Nature 328: 719-721.
10. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, et al. (1970) Typhoid fever: pathogenesis and immunologic control. N Engl J Med 283: 686-691.
11. Magnuson HJ, Thomas EW, Olansky S, Kaplan BI, De Mello L, et al. (1956) Inoculation syphilis in human volunteers. Medicine (Baltimore) 35: 33-82.
12. Cook GC, Zumla A, (2009) Manson's tropical diseases, 22nd edition. Edinburgh Saunders/Elsevier.
13. Wilcox M, Minton J, (2001) Role of antibody response in outcome of antibiotic-associated diarrhoea. Lancet 357: 158-159.
14. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, et al. (2010) Multilocus sequence typing of Clostridium difficile. J Clin Microbiol 48: 770-778.
15. Planche T, Wilcox M, (2011) Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol 64: 1-5.
16. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, et al. (2008) Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8: 777-784.
17. Best EL, Fawley WN, Parnell P, Wilcox MH, (2010) The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 50: 1450-1457.
18. Department of Health (2009) Clostridium difficile infection: how to deal with the problem. London Health Protection Agency.
19. Kyne L, Warny M, Qamar A, Kelly CP, (2000) Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342: 390-397.
20. McFarland LV, Mulligan ME, Kwok RY, Stamm WE, (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320: 204-210.
21. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, et al. (1994) Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 18: 181-187.
22. Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA, (2005) Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 26: 680-684.
23. Grundmann H, Barwolff S, Tami A, Behnke M, Schwab F, et al. (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33: 946-951.
24. Eastwood K, Else P, Charlett A, Wilcox M, (2009) Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47: 3211-3217.
25. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, et al. (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45: 992-998.
26. Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR, Daignault D, Janecko N, et al. (2009) Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis 15: 802-805.
27. Gould LH, Limbago B, (2010) Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis 51: 577-582.
28. Goldenberg SD, French GL, (2011) Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect 79: 4-7.
29. Wilcox MH, Eastwood K, (2009) Evaluation report: Clostridium difficile toxin detection assays. London NHS Purchasing and Supply Agency.
30. Broukhanski G, Simor A, Pillai DR, (2011) Defining criteria to interpret multilocus variable-number tandem repeat analysis to aid Clostridium difficile outbreak investigation. J Med Microbiol 60: 1095-1100.
31. Tanner HE, Hardy KJ, Hawkey PM, (2010) Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens. J Clin Microbiol 48: 985-987.
32. van den Berg RJ, Ameen HA, Furusawa T, Claas EC, van der Vorm ER, et al. (2005) Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol 54: 173-179.
33. Wroblewski D, Hannett GE, Bopp DJ, Dumyati GK, Halse TA, et al. (2009) Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol 47: 2142-2148.
34. Eyre DW, Walker AS, Griffiths D, Wilcox MH, Wyllie DH, et al. (2012) Clostridium difficile mixed infection and reinfection. J Clin Microbiol 50: 142-144.
35. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN, (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351: 633-636.
36. Wilcox MH, (2011) Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both? J Hosp Infect 79: 1-3.